Govt Recalls Popular Drug From All Pharmacies and Hospitals
The Pharmacy and Poisons Board has announced an immediate recall of Flamodip (Amlodipine) 5 mg tablets from batch number FLD303, which was manufactured by Medico Remedies PVT Limited.
This decision comes after the board identified a labeling error that did not correctly indicate the drug’s contents. The alert noted, “The secondary packaging is labeled as Flamodip-5 (Amlodipine), while the primary packaging is labeled as Flamidopril-5 (Enalapril).”
In a notice directed at pharmaceutical outlets, healthcare facilities, and professionals, the board instructed that all sales and distributions of the drug be halted immediately.
The public has been cautioned against consuming any medication from this batch and is urged to return any remaining tablets to their nearest healthcare facility or supplier.
Flamodip (Amlodipine) is a medication used to treat high blood pressure by relaxing blood vessels, which allows blood to flow more freely and reduces the heart’s workload.
Overdosing on this medication can lead to adverse reactions that primarily affect the blood and heart. Serious hemodynamic effects may occur, potentially resulting in pulmonary edema.
ALSO READ:
- Inside Job Exposed: Kenyan Prison Wardens Convicted for Orchestrating Daring Terrorist Escape
- Uganda Pulls the Plug: Nationwide Internet Blackout Ordered Days Before Crucial General Election
- African Elections Under the Spotlight as Zambia Turns to Kenya Ahead of 2026 Vote
- “Two Drug Barons in Cabinet?” Kenya Government Fires Back as Ex-Deputy President Sparks Explosive Drug Claims
- Kenyan Court Freezes Use of Private Lawyers by Government, Sparks Nationwide Legal Storm
Pulmonary edema is a serious condition characterized by fluid accumulation in the lungs, hindering proper breathing and leading to death, primarily due to underlying heart issues.
The board further encouraged the public to report any suspected cases of substandard medication or adverse drug reactions to healthcare providers or directly to the board through various channels.
Kenyan citizens can report issues by calling 0795743049 from a mobile phone or using the USSD code *271#.
Those with internet access can visit https://pv.pharmacyboardkenya.org/users/mpublic or download the mobile app mPvERS for reporting.
Additionally, emails can be sent to the board at pv@ppb.go.ke or pms@ppb.go.ke.
Govt Recalls Popular Drug From All Pharmacies and Hospitals
